Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non–small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study-Reference-Cited by-同舟云学术

Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non–small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study

Published:2018-11 Issue: Volume:125 Page:273-281
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Gadgeel Shirish M.,Stevenson James P.,Langer Corey J.,Gandhi Leena,Borghaei Hossein,Patnaik Amita,Villaruz Liza C.,Gubens Matthew,Hauke Ralph,Yang James Chih-Hsin^ORCID,Sequist Lecia V.,Bachman Robert,Saraf Sanatan,Raftopoulos Harry,Papadimitrakopoulou Vassiliki

Funder

Merck Sharp & Dohme Corp.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference25 articles.

1. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Non-Small Cell Lung Cancer. Version 5;National Comprehensive Cancer Network (NCCN),2018

2. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer;Sandler;N. Engl. J. Med.,2006

3. Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL);Reck;Ann. Oncol.,2010

4. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer;Johnson;J. Clin. Oncol.,2004

5. The blockade of immune checkpoints in cancer immunotherapy;Pardoll;Nat. Rev. Cancer,2012

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Triple therapy boosts survival in NSCLC patients with brain metastases: a retrospective cohort study of chemotherapy, ICIs, and antiangiogenic agents;Cancer Immunology, Immunotherapy;2024-09-06

2. The efficacy and safety of continuous intravenous infusion of rh-endostatin combined with platinum-based doublet chemotherapy for advanced non-small-cell lung cancer;Investigational New Drugs;2024-05-03

3. Complete remission in a pretreated, microsatellite-stable, KRAS-mutated colon cancer patient after treatment with sintilimab and bevacizumab and platinum-based chemotherapy: a case report and literature review;Frontiers in Immunology;2024-03-28

4. Prediction performance comparison of biomarkers for response to immune checkpoint inhibitors in advanced non‐small cell lung cancer;Thoracic Cancer;2024-03-25

5. Comparison of immune checkpoint inhibitors related to pulmonary adverse events: a retrospective analysis of clinical studies and network meta-analysis;BMC Medicine;2024-02-19